Abstract
This test is performed to evaluate HPA axis integrity. It is a sensitive alternative test to insulin tolerance test (ITT) in order to evaluate the adrenocorticotrophic hormone (ACTH) reserve.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fiad TM, Kirby JM, Cunningham SK, McKenna TJ. The overnight single‐dose metyrapone test is a simple and reliable index of the hypothalamic‐pituitary‐adrenal axis. Clin Endocrinol (Oxf). 1994;40(5):603–9.
Steiner H, Bähr V, Exner P, Oelkers P. Pituitary function tests: comparison of ACTH and 11-deoxy-cortisol responses in the metyrapone test and with the insulin hypoglycemia test. Exp Clinic Endocrinol Diabetes. 1994;102(01):33–8.
Gibney J, Healy M, Smith TP, McKenna TJ. A simple and cost-effective approach to assessment of pituitary adrenocorticotropin and growth hormone reserve: Combined use of the overnight metyrapone test and insulin-like growth factor-I standard deviation scores. J Clin Endocrinol Metab. 2008;93(10):3763–8.
Owen LJ, Halsall DJ, Keevil BG. Cortisol measurement in patients receiving metyrapone therapy. Ann Clin Biochem. 2010;47(6):573–5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ergin, A., Hamrahian, A., Kennedy, A., Gupta, M. (2015). Metyrapone Stimulation Test. In: The Cleveland Clinic Manual of Dynamic Endocrine Testing. Springer, Cham. https://doi.org/10.1007/978-3-319-13048-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-13048-4_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-13047-7
Online ISBN: 978-3-319-13048-4
eBook Packages: MedicineMedicine (R0)